SCM
HUMA icon

Sterling Capital Management’s Humacyte HUMA Stock Holding History

Sterling Capital Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,104
Closed -$3.1K – 3346
2026
Q1 		$3.1K Sell
5,104
-1,713
-25% -$1.78K ﹤0.01% 2885
2025
Q4 		$6.55K Buy
6,817
+120
+2% +$170 ﹤0.01% 2798
2025
Q3 		$11.7K Buy
6,697
+4,033
+151% +$7.9K ﹤0.01% 2410
2025
Q2 		$5.57K Buy
2,664
+2,575
+2,893% +$4.95K ﹤0.01% 2443
2025
Q1 		$152 Hold
89
– – ﹤0.01% 3115
2024
Q4 		$449 Hold
89
– – ﹤0.01% 3046
2024
Q3 		$484 Buy
+89
New +$587 ﹤0.01% 2884

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sterling Capital Management's HUMA Position: Q2 2026 in Review

Sterling Capital Management sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 5,104 shares — an estimated $3.1K sold.

Sterling Capital Management first reported a position in HUMA in Q3 2024 and held it in 7 quarters. The position peaked at $11.7K in Q3 2025. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Sterling Capital Management reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • Sterling Capital Management sold 5,104 Humacyte shares in Q2 2026, an estimated $3.1K.
  • Sterling Capital Management first reported a position in Humacyte in Q3 2024 and held it in 7 quarters.
  • Sterling Capital Management's Humacyte position peaked at $11.7K in Q3 2025.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.